Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Luminex Corporation To Present At Upcoming Investment Conferences



      Luminex Corporation To Present At Upcoming Investment Conferences

PR Newswire

AUSTIN, Texas, May 7, 2013

AUSTIN, Texas, May 7, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX)
announced today that management will present at three upcoming investment
conferences:

The UBS Global Healthcare Conference on Tuesday, May 21 at 1pm ET in New York
City

The Jefferies 2013 Global Healthcare Conference on Tuesday, June 4 at 1:30pm
ET in New York City, and

The Goldman Sachs 34^th Annual Global Healthcare Conference on Tuesday, June
11 at 1:20pm PT in Rancho Palos Verdes   

The presentations will be webcast live and may be accessed at Luminex
Corporation's website at http://www.luminexcorp.com.  Simply log on to the web
at the address above, go to the Company section and access the Investor
Relations link.  Please go to the website at least 15 minutes prior to the
event to register, download and install any necessary audio/video software. If
you are unable to participate during the live webcast, the presentation will
be archived for six months on the website using the 'replay' link.

Luminex is committed to applying its passion for innovation toward advancing
healthcare and research worldwide. We are transforming global healthcare and
life-science research through the development, manufacturing, and marketing of
proprietary instruments and assays utilizing our xMAP® open-architecture,
multi-analyte platform and our MultiCode® real-time polymerase chain reaction
(PCR) and multiplex PCR-based technologies that deliver cost-effective and
rapid results to clinicians and researchers. Our technology is commercially
available worldwide and in use in leading clinical laboratories as well as
major pharmaceutical, diagnostic, biotechnology and life-science companies. 
We are meeting the needs of customers in markets as diverse as clinical
diagnostics, pharmaceutical drug discovery, biomedical research including
genomic and proteomic research, personalized medicine, bio-defense research
and food safety.  For further information on Luminex Corporation and the
latest advances in multiplexing using award winning technology please visit
our website at http://www.luminexcorp.com.

(Logo:  http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

Contacts:   Matthew Scalo
            Sr. Director of Investor Relations
            512-219-8020
            mscalo@luminexcorp.com

SOURCE Luminex Corporation

Website: http://www.luminexcorp.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement